Simufilam Significantly Improves Cognition in Patients with Alzheimer’s in Interim Analysis of Open-label Study at 9 Months
Cognition Improved 3.0 Points on ADAS-Cog at 9 Months (p<0.001)
Cognitive Improvements Track with Biomarker Improvements
No Behavior Disorders in Over 50% of Patients
No Safety Issues
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.